table of content
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Therapeutics Overall Market Size
2.1 Global Precision Cancer Therapeutics Market Size: 2023 VS 2030
2.2 Global Precision Cancer Therapeutics Market Size, Prospects & Forecasts: 2020-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Therapeutics Players in Global Market
3.2 Top Global Precision Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Precision Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Precision Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precision Cancer Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Kinase Inhibitors
4.1.4 Angiogenesis Inhibitors
4.1.5 Proteasome Inhibitors
4.1.6 CAR-T Therapies
4.1.7 Other Precision Therapies
4.2 By Type - Global Precision Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Therapeutics Revenue, 2020-2024
4.2.2 By Type - Global Precision Cancer Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Therapeutics Market Size, 2023 & 2030
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Prostate Cancer
5.1.5 Colon and Rectal Cancer
5.1.6 Others
5.2 By Application - Global Precision Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Therapeutics Revenue, 2020-2024
5.2.2 By Application - Global Precision Cancer Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
6 Sights by Region
6.1 By Region - Global Precision Cancer Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Precision Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Therapeutics Revenue, 2020-2024
6.2.2 By Region - Global Precision Cancer Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Precision Cancer Therapeutics Revenue Market Share, 2020-2030
6.3 North America
6.3.1 By Country - North America Precision Cancer Therapeutics Revenue, 2020-2030
6.3.2 US Precision Cancer Therapeutics Market Size, 2020-2030
6.3.3 Canada Precision Cancer Therapeutics Market Size, 2020-2030
6.3.4 Mexico Precision Cancer Therapeutics Market Size, 2020-2030
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Therapeutics Revenue, 2020-2030
6.4.2 Germany Precision Cancer Therapeutics Market Size, 2020-2030
6.4.3 France Precision Cancer Therapeutics Market Size, 2020-2030
6.4.4 U.K. Precision Cancer Therapeutics Market Size, 2020-2030
6.4.5 Italy Precision Cancer Therapeutics Market Size, 2020-2030
6.4.6 Russia Precision Cancer Therapeutics Market Size, 2020-2030
6.4.7 Nordic Countries Precision Cancer Therapeutics Market Size, 2020-2030
6.4.8 Benelux Precision Cancer Therapeutics Market Size, 2020-2030
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Therapeutics Revenue, 2020-2030
6.5.2 China Precision Cancer Therapeutics Market Size, 2020-2030
6.5.3 Japan Precision Cancer Therapeutics Market Size, 2020-2030
6.5.4 South Korea Precision Cancer Therapeutics Market Size, 2020-2030
6.5.5 Southeast Asia Precision Cancer Therapeutics Market Size, 2020-2030
6.5.6 India Precision Cancer Therapeutics Market Size, 2020-2030
6.6 South America
6.6.1 By Country - South America Precision Cancer Therapeutics Revenue, 2020-2030
6.6.2 Brazil Precision Cancer Therapeutics Market Size, 2020-2030
6.6.3 Argentina Precision Cancer Therapeutics Market Size, 2020-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Therapeutics Revenue, 2020-2030
6.7.2 Turkey Precision Cancer Therapeutics Market Size, 2020-2030
6.7.3 Israel Precision Cancer Therapeutics Market Size, 2020-2030
6.7.4 Saudi Arabia Precision Cancer Therapeutics Market Size, 2020-2030
6.7.5 UAE Precision Cancer Therapeutics Market Size, 2020-2030
7 Precision Cancer Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Precision Cancer Therapeutics Major Product Offerings
7.1.4 AbbVie Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Astellas Pharma U.S., Inc
7.2.1 Astellas Pharma U.S., Inc Company Summary
7.2.2 Astellas Pharma U.S., Inc Business Overview
7.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Major Product Offerings
7.2.4 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.2.5 Astellas Pharma U.S., Inc Key News & Latest Developments
7.3 AstraZeneca PLC
7.3.1 AstraZeneca PLC Company Summary
7.3.2 AstraZeneca PLC Business Overview
7.3.3 AstraZeneca PLC Precision Cancer Therapeutics Major Product Offerings
7.3.4 AstraZeneca PLC Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.3.5 AstraZeneca PLC Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Precision Cancer Therapeutics Major Product Offerings
7.4.4 Bayer AG Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Bristol-Myers Squibb Company
7.5.1 Bristol-Myers Squibb Company Company Summary
7.5.2 Bristol-Myers Squibb Company Business Overview
7.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.5.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.6 Clovis Oncology, Inc.
7.6.1 Clovis Oncology, Inc. Company Summary
7.6.2 Clovis Oncology, Inc. Business Overview
7.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Major Product Offerings
7.6.4 Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.6.5 Clovis Oncology, Inc. Key News & Latest Developments
7.7 Dendreon Pharmaceuticals LLC
7.7.1 Dendreon Pharmaceuticals LLC Company Summary
7.7.2 Dendreon Pharmaceuticals LLC Business Overview
7.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Major Product Offerings
7.7.4 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.7.5 Dendreon Pharmaceuticals LLC Key News & Latest Developments
7.8 Eli Lilly & Company
7.8.1 Eli Lilly & Company Company Summary
7.8.2 Eli Lilly & Company Business Overview
7.8.3 Eli Lilly & Company Precision Cancer Therapeutics Major Product Offerings
7.8.4 Eli Lilly & Company Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.8.5 Eli Lilly & Company Key News & Latest Developments
7.9 EMD Serono, Inc. (Merck KgaA)
7.9.1 EMD Serono, Inc. (Merck KgaA) Company Summary
7.9.2 EMD Serono, Inc. (Merck KgaA) Business Overview
7.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Major Product Offerings
7.9.4 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.9.5 EMD Serono, Inc. (Merck KgaA) Key News & Latest Developments
7.10 Eisai Co., Ltd.
7.10.1 Eisai Co., Ltd. Company Summary
7.10.2 Eisai Co., Ltd. Business Overview
7.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Major Product Offerings
7.10.4 Eisai Co., Ltd. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.10.5 Eisai Co., Ltd. Key News & Latest Developments
7.11 Exelixis, Inc.
7.11.1 Exelixis, Inc. Company Summary
7.11.2 Exelixis, Inc. Business Overview
7.11.3 Exelixis, Inc. Precision Cancer Therapeutics Major Product Offerings
7.11.4 Exelixis, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.11.5 Exelixis, Inc. Key News & Latest Developments
7.12 Gilead Sciences, Inc.
7.12.1 Gilead Sciences, Inc. Company Summary
7.12.2 Gilead Sciences, Inc. Business Overview
7.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Major Product Offerings
7.12.4 Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.12.5 Gilead Sciences, Inc. Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Precision Cancer Therapeutics Major Product Offerings
7.13.4 GlaxoSmithKline Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.13.5 GlaxoSmithKline Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Precision Cancer Therapeutics Major Product Offerings
7.14.4 Johnson & Johnson Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Merck & Co., Inc.
7.15.1 Merck & Co., Inc. Company Summary
7.15.2 Merck & Co., Inc. Business Overview
7.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Major Product Offerings
7.15.4 Merck & Co., Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.15.5 Merck & Co., Inc. Key News & Latest Developments
7.16 Novartis AG
7.16.1 Novartis AG Company Summary
7.16.2 Novartis AG Business Overview
7.16.3 Novartis AG Precision Cancer Therapeutics Major Product Offerings
7.16.4 Novartis AG Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.16.5 Novartis AG Key News & Latest Developments
7.17 Otsuka Holdings Co., Ltd.
7.17.1 Otsuka Holdings Co., Ltd. Company Summary
7.17.2 Otsuka Holdings Co., Ltd. Business Overview
7.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Major Product Offerings
7.17.4 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.17.5 Otsuka Holdings Co., Ltd. Key News & Latest Developments
7.18 Pfizer, Inc.
7.18.1 Pfizer, Inc. Company Summary
7.18.2 Pfizer, Inc. Business Overview
7.18.3 Pfizer, Inc. Precision Cancer Therapeutics Major Product Offerings
7.18.4 Pfizer, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.18.5 Pfizer, Inc. Key News & Latest Developments
7.19 Puma Biotechnology, Inc.
7.19.1 Puma Biotechnology, Inc. Company Summary
7.19.2 Puma Biotechnology, Inc. Business Overview
7.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Major Product Offerings
7.19.4 Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.19.5 Puma Biotechnology, Inc. Key News & Latest Developments
7.20 Roche (F. Hoffman-La Roche, Ltd.)
7.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Summary
7.20.2 Roche (F. Hoffman-La Roche, Ltd.) Business Overview
7.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Major Product Offerings
7.20.4 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.20.5 Roche (F. Hoffman-La Roche, Ltd.) Key News & Latest Developments
7.21 Sanofi/Genzyme
7.21.1 Sanofi/Genzyme Company Summary
7.21.2 Sanofi/Genzyme Business Overview
7.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Major Product Offerings
7.21.4 Sanofi/Genzyme Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.21.5 Sanofi/Genzyme Key News & Latest Developments
7.22 Seagen Inc.
7.22.1 Seagen Inc. Company Summary
7.22.2 Seagen Inc. Business Overview
7.22.3 Seagen Inc. Precision Cancer Therapeutics Major Product Offerings
7.22.4 Seagen Inc. Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.22.5 Seagen Inc. Key News & Latest Developments
7.23 Takeda
7.23.1 Takeda Company Summary
7.23.2 Takeda Business Overview
7.23.3 Takeda Precision Cancer Therapeutics Major Product Offerings
7.23.4 Takeda Precision Cancer Therapeutics Revenue in Global Market (2020-2024)
7.23.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
